Analyst ratings for UiPath (NYSE:PATH) show a mix of bullish and bearish perspectives with 9 analysts offering evaluations over the past three months. The average 12-month price target for UiPath has increased to $22.33, up 17.53% from the previous target of $19.00. Several analysts from firms like Barclays, Canaccord Genuity, and JP Morgan have raised their price targets, reflecting a positive shift in expectations. UiPath's financial performance shows a solid revenue growth rate of 24.05% as of October 31, 2023, but struggles with below-industry averages in net margin, ROE, and ROA, indicating challenges in profitability and asset utilization.